No-Fault Compensation for Vaccine Injury — The Other Side of Equitable Access to Covid-19 Vaccines
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
No-Fault Compensation for Vaccine Injury Pharmaceutical companies won’t distribute Covid-19 vaccines to lower-income countries without liability protection. To efficiently handle claims, the COVAX ...
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the WHO Working Group also concluded that no-fault compensation schemes should be implemented to give people experiencing a serious vaccine adverse event (vaccine injury) access to a remedy without needing to resort to litigation (World Health Organization 2022; Halabi, Heinrich, and Omer 2020).”
From Ethical Principles in Legal Context: Vaccine Mandates During the COVID-19 Pandemic in Australia (2026) · cites this paper as Halabi, Heinrich, and Omer 2020
Citations
Cites
Mungwira, R. G., Guillard, C., Saldaña, A., Okabe, N., Petousis-Harris, H., Agbenu, E., Rodewald, L., & Zuber, P. L. F. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233334 · Cited by 68
Becker, M., Dörfler, T., & Gehring, T. (2018) · Regulation & Governance · doi:10.1111/rego.12195 · Cited by 6
Research works printed but not linked: 1
- Mello MM, 2008, Bioethics, 22, 32
Cited by
Wouters, O. J., Shadlen, K. C., Salcher-Konrad, M., Pollard, A. J., Larson, H. J., Teerawattananon, Y., & Jit, M. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00306-8 · Cited by 1,288
Enhancing public trust in COVID-19 vaccination: The role of governments
(2021) · OECD Policy Responses to Coronavirus (COVID-19) · doi:10.1787/eae0ec5a-en · Cited by 297
Boro, E., & Stoll, B. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.928065 · Cited by 100
“(71) 3 December, 2020 Commentary N/A 5 (Expert Opinion) Market forces; availability International & regional LMICs”
BackgroundPanneer, S., Kantamaneni, K., Palaniswamy, U., Bhat, L. D., Pushparaj, R. R. B., Nayar, K. R., Manuel, H. S., Flower, F. X. L. L., & Rice, L. (2022) · Healthcare · doi:10.3390/healthcare10050770 · Cited by 93
“Culturally tailored health communication measures [86], community engagement [87] and a robust pharmacovigilance system [88] are important strategies for addressing vaccine hesitancy.”
BackgroundEthics of ICU triage during COVID-19
Vinay, R., Baumann, H., & Biller‐Andorno, N. (2021) · British Medical Bulletin · doi:10.1093/bmb/ldab009 · Cited by 76
Metadata
- Authors
- Halabi, S., Heinrich, A., & Omer, S. B.
- Affiliations
- Yale University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-12-03
- Volume
- 383
- Issue
- 23
- Pages
- e125
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3095406687
- Cited by
- 44
- References
- 2
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 9 · 2021: 19 · 2020: 3
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Legal, Health, Environmental and COVID-19 Challenges
- Social Sciences › Law › Medical Malpractice and Liability Issues
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Keywords
- no-fault compensation, vaccine injury, COVID-19 vaccines, vaccine equity, pharmaceutical liability, COVAX, vaccine distribution, low-income countries
- MeSH terms
- COVID-19, COVID-19 Vaccines, Humans, Vaccination, Liability, Legal, Compensation and Redress, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.